Ligand validation:5OLX

BG6: 6-O-phosphono-beta-D-glucopyranose

BG6 is a Ligand Of Interest in 5OLX designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
5OLX_BG6_A_302	99%	34%	0.056	0.983	1.19	1.39	1	2	0	0	100%	1
6HDM_BG6_A_304	100%	63%	0.038	0.994	0.51	0.9	-	-	0	0	100%	1
6HDL_BG6_A_301	100%	62%	0.047	0.992	0.44	0.99	-	1	0	0	100%	1
3ZI4_BG6_A_1220	99%	8%	0.055	0.987	2.07	2.47	2	7	0	0	100%	1
2WF9_BG6_A_1224	97%	14%	0.062	0.98	2.25	1.67	5	5	0	0	100%	0.5
2WF5_BG6_A_1831	97%	55%	0.069	0.986	0.87	0.88	-	-	0	0	100%	1
5HJ5_BG6_A_302	99%	54%	0.06	0.989	0.65	1.1	-	2	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.